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Insulin nonattenuation of vasoactive agent-induced responses in mesan-
gial cells from spontaneously hypertensive rats. We recently found that
insulin attenuates intracellular calcium transients and cell contraction
caused by vasoactive agents in cultured rat mesangial cells. Because
altered glomerular function may be causally related to the evolution of
hypertension, we examined in the present study the effects of insulin on
the functions of mesangial cells derived from spontaneously hypertensive
rats (SHR) of 4- and 8-weeks of age. Age-matched Wistar Kyoto rats
(WKY) were used as controls, Intracellular calcium concentration
([Ca2],) was measured with Fura-2 method in suspended mesangial cells.
Pretreatment of mesangial cells with 5 sg/ml insulin for 120 minutes did
not affect basal [Ca2]1 in either WKY or SHR mesangial cells. However,
insulin pretreatment significantly attenuated [Ca21 transients to vasoac-
tive agents in WKY mesangial cells. In contrast, [Ca transients to these
agents were not attenuated by insulin in SHR mesangial cells. Addition-
ally, SHR mesangial cell contraction in response to angiotensin II (Ang II)
was not altered by insulin, while WKY mesangial cell contraction to Ang
II was, as in normal Wistar rats, significantly reduced by insulin. Since we
previously showed the possibility that the attenuation of calcium signal by
insulin is via insulin-like growth factor I (IGF-I) receptor, we also
examined the effect of IGF-I, In contrast to WKY mesangial cells,
IGF-I-induced attenuation of [Ca2]1 responses to platelet activating
factor was absent in SHR mesangial cells. [12511-IGF-I binding in SHR
mesangial cells was not significantly different from that in WKY mesangial
cells. These data clearly show that the attenuation of mesangial cell
[Ca2], responses and cell contraction by insulin, probably via IGF-I
receptor, is absent in SHR mesangial cells, which may render SHR
mesangial cells more sensitive to vasoactive agents.
It is known that the kidney plays an important role in the
evolution of hypertension [1—5]. Cross-transplantation experi-
ments revealed that the development of hypertension is causally
linked with disturbed kidney function [2—5]. For example, hyper-
tension developed in the Fl hybrids of spontaneously hyperten-
sive rats (SHR) and Wistar Kyoto rats (WKY) when they received
kidney transplantation from SHR, while hypertension did not
develop when they received kidney transplantation from WKY [2,
3]. Also, the glomerular pressure-filtration curve is shifted toward
higher blood pressure in hypertensive animal models as in pa-
tients with hypertension [6—8]. Thus, in hypertension, higher
blood pressure is necessary for the same amount of urinary
sodium excretion to occur.
We found recently that insulin, possibly via insulin-like growth
factor I (IGF-I) receptor, attenuates intracellular calcium re-
sponses and cell contraction caused by vasoactive agents such as
angiotensin II (Ang II), platelet activating factor (PAF), and
endothelin-1 (ET-1) in cultured mesangial cells from normal
Wistar rats [9]. Glomerular mesangial cells, located in the center
of glomerulus, are known to contract in response to these agents
[10—17], and are thought to modulate glomerular hemodynamics
[18—20]. Therefore, the modulation of mesangial cell function by
insulin or IGF-I via IGF-I receptor activation may also participate
in the regulation of glomerular filtration and disturbed modifica-
tion of mesangial cell function might be present in hypertensive
state. In the present study, we examined the effects of insulin on
the contraction responses to these vasoactive agents in mesangial
cells derived from SHR, and compared its effects with mesangial
cells from age-matched WKY. We found that the effects of insulin
are absent in mesangial cells from SHR.
Methods
Cell culture
Mesangial cells were obtained from male SHR of 4 and 8 weeks
of age, that is, before and during the development of hyperten-
sion, respectively. Mesangial cells were also obtained from age-
matched male WKY as controls by culturing isolated glomeruli at
37°C for 3 to 5 weeks in minimal essential medium (MEM)
containing 17% fetal calf serum (FCS) and 0.006% kanamycin
under humidified air containing 5% CO2 as reported previously
[10]. The rats were purchased from Charles River Japan (Atsugi,
Japan). In the present study, we used cultured mesangial cells of
3rd to 8th passages for the measurement of intracellular calcium
concentration ([Ca2]1), first and second passages for the exper-
iment of cell contraction, and 2nd to 4th passages for the binding
experiment of ['251]-IGF-I.
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Measurement of intracellular calcium concentration
[Ca2]1 was measured with fura-2 methods. Three to four days
before the experiments, mesangial cells were subcultured and
evenly divided into several culture dishes. Prior to the [Ca2]1
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monochrometer (CAF-ilO; Jasco, Tokyo, Japan) in a cuvette
under constant stirring. At the end of each experiment, the
maximum ratio of 500 nm fluorescence (Rm) of each aliquot was
obtained by permeabilizing cells with 0.1% Triton X, and the
minimum ratio of 500 nm fluorescence (Rmjn) was obtained by
adding EGTA at a final concentration of 20 mrt. [Ca2] was
calculated from these parameters as reported previously [21].
Cell contraction
Mesangial cell contraction was evaluated using a semiquantita-
tive analytical method as we reported previously [11]. In brief,
cells were partially detached from the floor of culture dish by
incubation at 37°C for 10 to 15 minutes in phosphate buffered
saline (PBS) containing 0.54 mivi EDTA. The cells thus treated
were incubated again in MEM containing 17% FCS at 37°C for 30
minutes under humidified air containing 5% C02, and then the
medium was changed to an experimental solution containing 0.8%
BSA in the presence of 5 g/ml insulin or vehicle. After 30
minutes of incubation at 37°C, photographs of randomly selected
areas were taken before and at 50 to 70 seconds after the addition
of 100 nM Ang II. Comparing the cell shape before and after the
addition of Ang II, the percentage of the cells showing unequiv-
ocal shape changes was calculated.
[1251]-IGF-I binding study
Fig. 1. [Ca2] responses of 8-week-old WKYmesangial cells to 100 nM PAF
after the pretreatment in the presence of 5 pg/mI insulin or vehicle for 120
mm. (A) The effect of insulin pretreatment on the Ca2]1 response
induced by 100 nM PAF. Preincubation with insulin did not affect the basal
[Ca2J, while Ca2 transient induced by PAF was markedly attenuated by
insulin pretreatment. (B) The basal [Ca2I and the peak value of [Ca2]1
induced by 100 nM PAF from seven independent experiments. There was
no significant change induced by insulin in the basal [Ca2]1, whereas the
peak value of [Ca2]1 was significantly suppressed by insulin pretreatment.
The values in B are means SD of 7 independent experiments. **p < 0.01
vs. the value in the absence of insulin.
measurement, these same batches of cells were exposed to 5
g/ml insulin or vehicle for 120 minutes. This condition was
ascertained to cause maximum insulin effect in our previous
report [9]. Sixty minutes before the end of incubation period, each
batch of cells was detached from the floor of culture dish with
trypsin-EDTA solution (containing 0.05% porcine tiypsin and
0.53 mivi EDTA-4Na) and loaded with fura-2 (2.5 .LM) in the
continued presence of insulin or vehicle for 30 minutes at 37°C.
When fura-2 loading was completed, each batch of cells was
resuspended in the standard experimental solution with or with-
out insulin and [Ca2] measurement was performed immediately
after the baseline Ca2 signal was stabilized. The ratio of 500 nm
fluorescence signal obtained by exciting the cells with 340 and 380
nm wavelength (R) was monitored at 37°C using a dual excitation
We used cells grown to confluence in 24-well culture dishes for
binding studies. Experiments were routinely performed in binding
buffer consisting of MEM with 0.1% BSA and 25 mM Hepes at
4°C. Cells were washed three times with PBS and then exposed to
binding buffer containing 30 M [1251]-IGF-I in the presence of
increasing concentrations (0.01 to 30 nM) of cold IGF-I for four
hours. Binding experiments at each concentration of cold IGF-I
were performed in triplicate. At the completion of the experi-
ment, the binding buffer was removed and the cells were washed
twice with ice cold PBS. Then the cells were dissolved with 0.5 ml
of 1.0 N NaOH and transferred to small tubes for determination of
the bound radioactivity using a gamma counter. Specific binding
was determined for each concentration, and values for maximal
binding capacity (Bm) and the dissociation constant (Kd) were
calculated using Scatchard analysis.
Solutions and reagents
The composition of the standard experimental solution was (in
mM): Na 150, K 6, Ca2 1.2, Mg2 1.0, Hepes 20, Cl 140, and
glucose 5.5; pH 7.4. NaOH (10—i N or less) was used for the
vehicle of insulin, and acetic acid (10 N) was used for that of
insulin-like growth factor I (IGF-I). PAF, Ang II, ET-1 and
trypsin-EDTA solution were purchased from Sigma Chemical Co.
(St. Louis, MO, USA). Insulin was obtained from BIOSYS S. A.
(Compiegne, France) and IGF-I was purchased from GIBCO
BRL (Gaithersburg, MD, USA). ['251]-IGF-I was obtained from
Amersham International plc (Buckinghamshire, UK).
Statistics
The data are presented as mean SD. Analysis of variance was
used to test overall differences between groups. Paired t analysis
was used for statistical analysis unless otherwise specified.
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Vasoactive agents
(100 flM)
[Ca2], nM PAF Ang II ET-l
Insulin (—) Base 74 21 98 8 78 21
(control) Peak
Increment
501 63
427 50
174 38
76 34
135 1458 7
Insulin (+) Base
Peak
Increment
% inhibition of the
increment in [Ca2],
vs. control
71 16
404 59b
333 50b
22%
95 18
149 39
26k'
30%
78 26
119 20
41 9b
28%
Number of 7 6 6
experiments
Results
Effects of insulin on basal [Ca2] and [Ca2] responses to PAF
in 8-week-old WKY and SHR mesangial cells
Figure 1A represents the effect of insulin on the [Ca2]
response to 100 nM PAP in cultured mesangial cells derived from
8-week-old WKY. The peak of Ca2 transient was apparently
attenuated by the pretreatment with 5 tg/ml insulin for 120
minutes. Including other experiments, Figure lB summarizes the
basal [Ca2]1 and the peak value of [Ca2]1 induced by PAF (N =
7). Insulin pretreatment did not affect the basal [Ca2] [74 21
flM vs. 71 16 n, insulin (—) vs. (+); N = 7], while the peak
value of [Ca2]1 induced by PAF was significantly attenuated by
insulin [501 63 n vs. 404 59 nrvi, insulin ()vs. (+); N = 7,
P < 0.01]. These data are summarized in Table 1.
In contrast to WKY, the peak value of Ca2 transient caused by
100 nM PAP was not attenuated by insulin in mesangial cells from
SHR which were 8 weeks old (Fig. 2A). The data obtained from
10 independent experiments are represented in Figure 2B and
Table 2. Similar to WKY, insulin pretreatment did not affect the
basal [Ca2] [64 9 nM vs. 63 13 n, insulin (—) vs. (+); N =
101. However, the peak value of {Ca2]1 induced by PAP was not
altered by insulin pretreatment in SHR mesangial cells [the peak
value of [Ca2]1, 192 46 n vs. 190 46 n, insulin (—)vs.
N = 10].
To exclude the possibility that insulin did not alter [Ca2J
responses to 100 nM PAP in 8-week-old SHR mesangial cells
because PAP-induced [Ca2] responses in SHR reached the
maximum responses, we also examined the effects of insulin on
[Ca2] responses to a lower dose of PAP (10 nM) in SHR
mesangial cells. As shown in Figure 3, the increment in [Ca2]
caused by 10 nM PAP, which was significantly less than that by 100
nM PAP, was not altered by insulin pretreatment in SHR mesang—
ial cells. Thus, it seems that insulin did not affect the PAP-induced
responses in SHR mesangial cells.
In all these experiments, insulin per se had no effects on [Ca2]1.
Effects of insulin on [Ca2]1 responses to Ang II and ET-1 in 8-
week-old WKY and SHR mesangial cells
The effects of insulin pretreatment on [Ca2] responses to Ang
II and ET-1 were also examined in 8-week-old WKY and SHR
Fig. 2. [Ca2J, responses of 8-week-old SHR mesangial cells to 100 nM PAF
after the pretreatment in the presence of 5 igIml insulin or vehicle for 120
mm. (A) The effect of insulin pretreatment on the [Ca2j1 response
induced by 100 ns PAF. Preincubation with insulin did not affect the basal
[Ca2]. In contrast to WKY, the peak of Ca2 transient caused by PAF
was not attenuated by insulin in SHR mesangial cells. (B) The basal
[Ca2]1 and the peak value of [Ca2]1 induced by 100 nM PAF from ten
independent experiments. Similar to WKY, there was no significant
change induced by insulin in the basal [Ca2}. Moreover, the peak value
of [Ca2J, induced by PAF was not altered by insulin pretreatment in SHR
mesangial cells in contrast with WKY. The values in B are means SD of
10 independent experiments.
mesangial cells. These data are summarized in Tables 1 and 2.
Pretreatment of WKY mesangial cells with 5 g/ml insulin for 120
minutes significantly attenuated the peak value of [Ca2]1 induced
by 100 nM Ang II and ET-1 (Table 1). By contrast, insulin did not
attenuate in SHR mesangial cells the peak value of [Ca2]1
induced by Ang II and ET-1 (Table 2).
Effects of insulin on [Ca2J responses to PAF, Ang II, and ET-1
in 4 weeks WKY and SHR mesangial cells
To exclude the possibility that the lack of insulin effect observed
in 8-week-old SHR mesangial cells is secondary to the hyperten-
sion already developed in SHR, we examined the effects of insulin
on [Ca2]1 responses induced by PAP, Ang II, and ET-1 in
cultured mesangial cells from SHR of 4 weeks of age. At this age,
SHR were normotensive, and age-matched WKY were used as
Table 1. Effects of insulin on [Ca2] responses to PAF, Ang II, and
ET-1 in 8-week-old WKY mesangial cells
A
Insulin (—) Insulin 5 gig/mI
150
100
50
+
C)
Cells were pretreated in the presence of 5 jig/mI insulin [insulin (+)] or
vehicle [insulin (—)] for 120 mm. The values are means SD.aP < 0.05 vs. the value in the absence of insulin (control)
hp < 0.01 vs. control
1mm 1mm
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Vasoactive agents
(100 nM)
[Ca2], flM PAF Ang II ET-1
Insulin (—)
(control)
Base
Peak
Increment
64 9
192 46
128 46
147 24
284 64
137 52
65 12
253 105
188 112
Insulin (+) Base
Peak
Increment
% inhibition of the
increment in [Ca2]1
vs. control
63 13
190 46
127 43
1%
150 21
295 74
146 60
—7%
71 21
251 86
180 96
5%
Number of 10 6 6
experiments
8 7 6
— log [PAF], M
Fig. 3. The increment in [Ca27 induced by 10 and 100 nM PAF after the
pretreatment in the presence of 5 ,ug/ml insulin (----) or vehicle (—) for 120
mm in 8-week-old SHR mesangial cells. Each point represents the mean
SD of five independent experiments. The increment in [Ca2], caused by 10
nM PAF, which was significantly less than that by 100 nM PAF, was not
altered by insulin pretreatment in SHR mesangial cells.
the control. Similar to 8-week-old WKY and SHR mesangial cells,
insulin significantly attenuated the peak value of [Ca2I, induced
by 100 flM PAF as well as those by Ang II and ET-1 in WKY
mesangial cells (Table 3), while insulin did not alter the peak
value of [Ca2], induced by PAF and also those by Ang II and
ET-1 in SHR mesangial cells (Table 4).
Effects of insulin on cell contraction induced by Ang II
The effects of insulin on mesangial cell contraction were
evaluated using a semiquantitative analytical method as previ-
ously reported [11]. Pretreatment of WKY mesangial cells with 5
Vasoactive agents
(100 nM)
[Ca2], flM PAF Ang II ET-1
Insulin (—) Base 87 6 94 10 106 38
(control) Peak
Increment
257 46
170 45
176 36
82 28
185 56
79 22
Insulin (+) Base
Peak
Increment
% inhibition of the
increment in [Ca2I1
vs. control
90 18
218 28
128 29"
24%
88 18
145 41"
56 24b
32%
102 37
157 45
55 10"
31%
Number of 6 6 6
experiments
Vasoactive agents
(100 nM)
([Ca21, nM PAF Ang II ET-1
Insulin (—) Base 60 3 135 27 124 52
(control) Peak
Increment
128 568 3 256 72121 56 294 23170 55
Insulin (+) Base
Peak
Increment
% inhibition of the
increment in [Ca2],
vs. control
73 13
140 1167 3
2%
142 22
265 64
123 52
—2%
126 53
288 23
161 46
5%
Number of 6 6 6
experiments
j.tg/ml insulin for 30 minutes suppressed cell contraction in
response to 100 nM Ang II (8 weeks, 74 2% vs. 36 13%; 4
weeks, 53 21% vs. 31 14%, insulin (—) vs. (+), respectively;N = 3, P < 0.01; Fig. 4A). By contrast, insulin did not attenuate
cell contraction by Ang II in SHR mesangial cells with and
without hypertension (8 weeks, 49 11% vs. 57 15%; 4 weeks,
42 14% vs. 49 6%, insulin (—) vs. (+), respectively; N = 3;
Fig. 4B).
Effects of IGF-I on [Ca2 47, responses to PAF in 8-week-old WKY
and SHR mesangial cells
Our recent observations demonstrated that the attenuation of
mesangial cell responses to vasoactive agents by insulin is via the
IGF-I receptor [9]. Therefore, we examined the effects of IGF-I
on [Ca2], responses to PAF in 8-week-old WKY and SHR
mesangial cells. IGF-1 at the concentration of 50 ng/ml, a concen-
tration almost equivalent to that found in vivo, was used. Similar
to insulin pretreatment, IGF-1 pretreatment for 120 minutes
significantly attenuated the peak value of [Ca2], induced by 100
flM PAF in WKY mesangial cells, while IGF-I did not alter the
peak value of [Ca2J, induced by PAF in SHR (Fig. 5).
Table 2. Effects of insulin on [Ca2], responses to PAF, Ang II, and
ET-1 in 8-week-old SHR mesangial cells
Table 3. Effects of insulin on [Ca2], responses to PAF, Ang II, and
ET-1 in 4-week-old WKY mesangial cells
Cells were pretreated in the presence of 5 giml insulin [insulin (+)] or
vehicle [insulin (—)] for 120 mm. The values are means SD.
P < 0.05 vs. the value in the absence of insulin (control)
b p < 0.01 vs. control
Table 4. Effects of insulin on [Ca21, responses to PAF, Ang II, and
ET-1 in 4-week-old SHR mesangial cells
Cells were pretreated in the presence of 5 jtg/ml insulin [insulin (+)I or
vehicle [insulin (—)] for 120 mm. The values are means SD.
250
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Cells were pretreated in the presence of 5 giml insulin Linsulin (+)} or
vehicle [insulin (—)j for 120 mm. The values are means SD.
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WKY SHR
Fig. 5. [Ca2] responses of 8-week-old WKvmesangial cells to 100 nMPAF
after the pretreatment in the presence of 50 ng/ml IGF-I or vehicle for 120
mm. IGF-I did not affect the basal [Ca2]1 in both WKY and SHR
mesangial cells. In WKY mesangial cells, IGF-I pretreatment significantly
attenuated the peak value of [Ca2I1 induced by PAF, while IGF-I did not
alter the peak value of [Ca2]1 induced by PAF in SHR. The values are
means SD of 5 independent experiments. < 0.01 vs. the value in the
absence of IGF-I.
Discussion
WKY SHR
Fig. 4. Cell contraction in response to 100 nMAng II after the pretreatment
in the presence of 5 pg/mI insulin or vehicle in mesangial cells from WKYand
SHR of 4 and 8 weeks of age. In WKY mesangial cells of 4 (B, left side) and
8 (A, left side) weeks of age, insulin pretreatment significantly suppressed
percentage of cell showing contraction in response to 100 nM Ang LI.
Apparent cell contraction caused by Ang II was not altered by insulin in
SHR mesangial cells of 4 (B, right side) and 8 (A, right side) weeks of age.
The values are means SD of 3 and 4 independent experiments in 4- and
8-week-old rats, respectively. In each experiments, at least 60 cells were
examined. < 0.01 vs. the value in the absence of insulin.
Binding of IGF-I in 4-week-old WKY and SHR mesangial cells
We also examined whether the binding of IGF-I in SHR
mesangial cells was different from that in WKY mesangial cells.
Figure 6 depicts the percent inhibition of binding of 30 M
['251]-IGF-I by cold IGF-I (0.01 to 30 nM). Scatchard transforma-
tion of the binding data revealed a single class of high affinity
binding sites for IGF-I in both WKY and SHR (Fig. 7). Bm,and
K.d of IGF-I binding sites in SHR mesangial cells were not
different significantly from those in WKY mesangial cells (Table
5).
The present study clearly shows that the modification of
mesangial cell responses to vasoactive agents, that is, [Ca2]1
responses and cell contraction, by insulin is lacking in SHR
mesangial cells. These data suggest that the insensitivity of SHR
mesangial cells to insulin leads to their hypersensitivity to vaso-
active agents. Moreover, these phenomena might be related to the
abnormal renal hemodynamics present in SHR since mesangial
cell contraction in response to various vasoactive agents is gener-
ally believed to modulate intraglomerular hemodynamics, proba-
bly by affecting glomerular filtration coefficient (Kf) [18—20]. In
this context, Kost and Jackson demonstrated that SHR have
enhanced renal sensitivity to Ang II, and a decrease in glomerular
filtration rate (GFR) mediated by Ang II subtype 1 receptor [221.
Also, abnormal regulation of mesangial cells would lead to the
disturbed glomerular function in SHR kidney, which includes an
abnormal pressure-diuresis curve [6, 8], an enhanced tubuloglo-
merular feedback [23], and a decrease in K.f [24]. All these
observations may be partially explained by our results. These and
other alterations of glomerular function in SHR might be causally
related to the development of hypertension. In addition to our
recent report that the modulation of mesangial cell function by
ambient chloride ions is also lacking in SHR mesangial cells [25],
the present observation gives other evidence that the regulation of
mesangial cell function and possibly glomerular function of SHR
is deviated from normal.
The present data that the mesangial cell Ca signal failed to be
suppressed by insulin and that SHR mesangial cells thus show
hyperreactivity to vasoactive agents including Ang II, PAF, and
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Fig. 6. Percent binding of 30 pt ['251J-IGF-I in the presence of increasing
concentrations of cold IGF-I in mesangial cells from WKY and SHR of 4
weeks of age. Each point represents the mean so of three (A) or four (B)
independent experiments. Binding of F'2511-IGF-I decreased progressively
with increasing concentrations of cold IGF-I in both WKY (A) and SHR
(B) mesangial cells.
ET-1, are in accordance with the previously reported abnormal Ca
metabolism in SHR. Kravtsov, Orlov and Postnov reported that
45Ca uptake by SHR platelets is higher than in platelets from
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Fig. 7. Scatchard analysis of the binding data. Scatchard transformation
revealed a single class of high affinity binding sites in both 4-week-old
WKY (A) and SHR (B) mesangial cells. Bmax and K. values of IGF-I
binding sites in WKY mesangial cells were 8640.6 fmol/mg protein and
0.96 nM, respectively (A), and those in SHR were 10047.5 fmol/mg protein
and 1.32 flM, respectively (B), for each representative experiment.
normotensive WKY {26]. Also, Erne et al demonstrated a close
correlation between [Ca2I1 in platelets and both systolic and
diastolic blood pressures in normotensive subjects and patients
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Table 5. IGF-I binding sites in 4-week-old WKY and SHR
mesangial cells
Bm finollmg
protein Kd nM
Number of
experiments
WKY 8481.0 127.4 0.90 0.04 3
SHR 7248.0 1636.0 0.93 0.24 4
The values represent means so of three (WKY) or four (SHR)
different experiments.
with hypertension [27]. Therefore, our present results strengthen
the notion that abnormal Ca metabolism is present in SHR and
this might be related to the development of hypertension.
This abnormality of insulin responsiveness seems to be specific
for SHR mesangial cells since our recent examination revealed
that Ca signal attenuation by insulin is present in mesangial cells
from Dahi salt-sensitive rats, another model of hypertension [28].
In addition, our preliminary observation failed to show that
insulin attenuates [Ca2]1 responses to vasoactive agents in nor-
mal vascular smooth muscle cells (data not shown), indicating the
specific role of insulin in mesangial cells.
In the present study, it is unlikely that the secondary effects of
hypertension on original mesangial cells in vivo caused the
discrepant modulation of cultured mesangial cells from 8-week-
old SHR and age-matched WKY, since essentially similar results
were obtained with cultured mesangial cells from 4-week-old SHR
and WKY. At 4 weeks of age, hypertension had not developed in
SHR. Therefore, although indirect, this indicates that the present
observation might be genetically related to the development of
hypertension in SHR.
The suppressive effects of insulin seem to be via the IGF-I
receptor. In previous work using mesangial cells from normal
Wistar rats, we showed that the attenuation of mesangial cell
responses to vasoactive agents by insulin is via the IGF-I receptor
since the effective dose of insulin was unphysiologically high
(higher than 0.5 j.gIml), and a physiological dose of IGF-I (50
nglml) similarly suppressed the PAF-induced mesangial cell re-
sponses [9]. Therefore, the lack of insulin-dependent suppression
of SHR mesangial cell responses to vasoactive agents is possibly
due to altered binding/signaling of the IGF-I receptor. Indeed,
IGF-I (50 nglml) failed to suppress {Ca2] responses to PAF in
SHR mesangial cells, while pretreatment of WKY mesangial cells
with IGF-I significantly attenuated [Ca2] responses to PAF.
Further, in the present study, we demonstrated that Bm.and Kd
of IGF-I binding sites in SHR mesangial cells were not signifi-
cantly different from those in WKY mesangial cells. These
observations strongly suggest that post-receptor signaling abnor-
malities of IGF-I may underlie the absence of mesangial cell
function modulation by insulin and IGF-I.
IGF-I could be an important regulator of mesangial cells and
glomerular function. It is known that mesangial cell produces and
secretes IGF-I [29] and IGF-I modulates mesangial cell function
in normal rats as we and others reported in the previous and
present studies [9, 30, 31]. Thus, IGF-I could act in an autocrine!
paracrine manner in glomerulus. More interestingly, Hirschberg
et al demonstrated that infusion of IGF-I increases GFR [32].
According to their data, the increase in GFR by IGF-I is mediated
by the increase in K1. These observations strongly suggest that
IGF-I modulates glomerular hemodynamics through affecting
mesangial cell responses to vasoactive agents, since mesangial cell
contraction seems to be an important determinant of Kf. These
data suggest that the effect of IGF-I on GFR in SHR is also
deviated from normal. Our preliminary experiments show that
GFR did not increase by IGF-I in SHR, in contrast to WKY [33].
Recently, various studies have shown that hypertension is
related to hyperinsulinemia or insulin resistance in human and
experimental animal models including SHR [34—38]. Our present
observation concerning SHR mesangial cell insensitivity to insulin
might be of significance in this context. As mentioned above,
however, different modulation of mesangial cell functions by
insulin between WKY and SHR may be through different IGF-I
receptor functions. Thus, the present data could not be directly
coupled with the insulin resistance in hypertensive states. Still,
there remains the possibility that the insensitivities to IGF-I and
physiological effects of insulin reflect the common abnormality
present in SHR since IGF-I and insulin share the same signal
transduction mechanisms.
Based on the present and previous observations, mesangial cell
dysfunction in SFIR, at least in part, plays an important role in the
altered glomerular function leading to the development of hyper-
tension.
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